Emma Matthews Selected Research

Hyperkalemic Periodic Paralysis

7/2021	Ageing contributes to phenotype transition in a mouse model of periodic paralysis.
1/2020	In vivo assessment of interictal sarcolemmal membrane properties in hypokalaemic and hyperkalaemic periodic paralysis.
1/2018	Hypokalaemic periodic paralysis and myotonia in a patient with homozygous mutation p.R1451L in NaV1.4.
4/2013	Prevalence study of genetically defined skeletal muscle channelopathies in England.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emma Matthews Research Topics

Disease

12	Channelopathies 01/2022 - 10/2007
11	Myotonia 10/2021 - 02/2011
8	Paralysis (Palsy) 07/2021 - 03/2010
5	Muscular Diseases (Myopathy) 01/2021 - 03/2010
4	Myotonia Congenita (Thomsen Disease) 01/2022 - 02/2011
4	Sudden Infant Death (SID) 01/2022 - 01/2018
4	Hyperkalemic Periodic Paralysis 07/2021 - 04/2013
3	Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic) 11/2019 - 04/2013
3	Rare Diseases (Rare Disease) 12/2018 - 10/2012
2	Epilepsy (Aura) 01/2022 - 01/2020
2	Cardiac Arrhythmias (Arrythmia) 01/2022 - 01/2020
2	Andersen Syndrome 01/2022 - 04/2013
2	Myotonic Dystrophy (Dystrophia Myotonica) 10/2021 - 07/2013
2	Muscle Weakness 07/2021 - 01/2018
2	Nondystrophic myotonia 12/2018 - 10/2012
2	Myalgia 01/2018 - 08/2011
2	Myotonic Disorders (Paramyotonia Congenita) 04/2013 - 01/2011
1	Neurodevelopmental Disorders 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Contracture 07/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2021
1	Hypertrophy 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Neuromuscular Diseases (Neuromuscular Disease) 12/2018
1	Strabismus (Squint) 01/2017
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 05/2016
1	Weight Gain 05/2016
1	Myositis (Idiopathic Inflammatory Myopathies) 08/2011
1	Myofibrillar Myopathy 01/2011
1	Respiratory Sounds (Crackle) 01/2011
1	Minicore Myopathy with External Ophthalmoplegia 03/2010

Drug/Important Bio-Agent (IBA)

9	SodiumIBA 01/2022 - 10/2007
8	Sodium Channels (Sodium Channel)IBA 01/2022 - 10/2007
6	Mexiletine (Mexitil)FDA LinkGeneric 10/2021 - 01/2011
5	Voltage-Gated Sodium ChannelsIBA 01/2022 - 01/2018
5	Chloride Channels (Chloride Channel)IBA 01/2022 - 02/2011
3	Ion Channels (Ion Channel)IBA 07/2021 - 10/2012
3	PotassiumIBA 07/2021 - 01/2018
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2018 - 03/2010
2	ChloridesIBA 07/2013 - 08/2011
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Potassium Channels (Potassium Channel)IBA 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 07/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	ConnectinIBA 01/2021
1	MagnesiumIBA 01/2020
1	Bumetanide (Bumex)FDA LinkGeneric 01/2020
1	safinamideIBA 01/2020
1	triadinIBA 01/2020
1	Arginine (L-Arginine)FDA Link 11/2019
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2019
1	CalciumIBA 12/2018
1	Amino Acids FDA Link 01/2018
1	CLC-1 channelIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2016
1	Prednisone (Sone)FDA LinkGeneric 05/2016
1	deflazacortIBA 05/2016
1	N-desmethylstobadineIBA 10/2012
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2011
1	DNA (Deoxyribonucleic Acid)IBA 02/2011
1	Crystallins (Crystallin)IBA 01/2011
1	Small Heat-Shock ProteinsIBA 01/2011

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2020
1	Patient Admission (Patient Admissions) 01/2020
1	Rewarming 02/2011